Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OZ439 and DSM265 in early Plasmodium falciparum infection
NCT02389348Phase 2Completed
- Sponsor
- Medicines for Malaria Venture
- Start
- Feb 2015
- Primary completion
- Jun 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of artefenomel, DSM265 in malaria, sponsored by Medicines for Malaria Venture. Started Feb 2015; status: completed.
02
Drugs
artefenomelDSM265
03
Conditions
malaria
Beyond the preview
Go deeper on NCT02389348.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02389348.